Literature DB >> 10971188

Effect of insulin-like growth factors 1 and 2, and glucose on the migration and proliferation of bovine retinal pigment epithelial cellsin vitro.

C W Spraul1, C Kaven, J Amann, G K Lang, G E Lang.   

Abstract

BACKGROUND: The retinal pigment epithelium (RPE) has been implicated in the development of diabetic retinopathy and it has been suggested that insulin-like growth factors (IGF) and glucose may be among those factors which are responsible for the RPE changes in diabetics. The purpose of this study was to investigate the effect of IGF-1, IGF-2, and glucose on the migration and proliferation of bovine RPE cells in vitro.
METHODS: Primary cultures of bovine RPE cells were established from freshly enucleated eyes and passages 5-8 were used for these experiments. RPE cell migration was studied in confluent RPE cultures grown in multiwell plates. After inhibition of proliferation with mitomycin C (10 microg/ml) and partial denudation of the RPE in each well, the cells were incubated with IGF-1 (10 ng/ml), IGF-2 (10 ng/ml) or glucose (10 mM). Migration was measured as the number of cells that had entered the denuded area after 20 h. RPE cell proliferation was determined by [(3)H]-thymidine incorporation after incubation with IGF-1, IGF-2, and glucose for 24 h. Statistical analysis was performed with the paired Student's t test.
RESULTS: Exposure of RPE cells to IGF-1, IGF-2, and glucose resulted in a significantly higher RPE cell migration as compared to the control medium (p < 0.008) with 21, 20, 17, and 9 cells/raster field, respectively. Additionally, IGF-1 (p = 0.004) and IGF-2 (p = 0.008) but not glucose caused a statistically significant stimulation of DNA synthesis with 761, 747, and 593 ccpm, respectively, as compared to the negative control (352 ccpm).
CONCLUSION: This study indicates that IGF-1 and IGF-2 influence RPE cell migration and proliferation. This is further evidence that these factors are among those which have to be kept in mind when trying to modulate the development of diabetic eye diseases. Copyright 2000 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10971188     DOI: 10.1159/000055621

Source DB:  PubMed          Journal:  Ophthalmic Res        ISSN: 0030-3747            Impact factor:   2.892


  6 in total

1.  Elevated serum IGF-1 level enhances retinal and choroidal thickness in untreated acromegaly patients.

Authors:  Xia Zhang; Jin Ma; Yuhan Wang; Lüe Li; Lu Gao; Xiaopeng Guo; Bing Xing; Yong Zhong
Journal:  Endocrine       Date:  2018-01-10       Impact factor: 3.633

2.  The study of chemiluminescence in gastric and colonic carcinoma cell lines treated by anti-tumor drugs.

Authors:  Che Chen; Fu-Kun Liu; Xiao-Ping Qi; Jie-Shou Li
Journal:  World J Gastroenterol       Date:  2003-02       Impact factor: 5.742

3.  Gene expression of IGF1, IGF1R, and IGFBP3 in epiretinal membranes of patients with proliferative diabetic retinopathy: preliminary study.

Authors:  Dorota Romaniuk; Malgorzata W Kimsa; Barbara Strzalka-Mrozik; Magdalena C Kimsa; Adam Kabiesz; Wanda Romaniuk; Urszula Mazurek
Journal:  Mediators Inflamm       Date:  2013-11-28       Impact factor: 4.711

4.  Two Bioactive Molecular Weight Fractions of a Conditioned Medium Enhance RPE Cell Survival on Age-Related Macular Degeneration and Aged Bruch's Membrane.

Authors:  Ilene K Sugino; Qian Sun; Carola Springer; Noounanong Cheewatrakoolpong; Tong Liu; Hong Li; Marco A Zarbin
Journal:  Transl Vis Sci Technol       Date:  2016-02-22       Impact factor: 3.283

5.  Downregulation of miR-637 promotes vascular smooth muscle cell proliferation and migration via regulation of insulin-like growth factor-2.

Authors:  Ning Yang; Bo Dong; Yanqiu Song; Yang Li; Lu Kou; Jingyu Yang; Qin Qin
Journal:  Cell Mol Biol Lett       Date:  2020-05-07       Impact factor: 5.787

6.  IGF1 gene polymorphisms associated with diabetic retinopathy risk in Chinese Han population.

Authors:  Jian Zhang; Xiao Chen; Like Zhang; Yi Peng
Journal:  Oncotarget       Date:  2017-09-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.